Brian E. Mcdowell

Array ( [id] => 7744914 [patent_doc_number] => 20120022256 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'Novel Hydrated Form of Erlotinib Free Base and a Process For Preparation Of Erlotinib Hydrochloride Polymorph Form A Substantially Free of Polymorph Form B' [patent_app_type] => utility [patent_app_number] => 13/221986 [patent_app_country] => US [patent_app_date] => 2011-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6586 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20120022256.pdf [firstpage_image] =>[orig_patent_app_number] => 13221986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7663885 [patent_doc_number] => 20110313154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-22 [patent_title] => 'METHOD FOR PREPARING PHENYLALANINE DERIVATIVES HAVING QUINAZOLINE-DIONE SKELETON AND INTERMEDIATES FOR USE IN THE PREPARATION OF THE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 13/218946 [patent_app_country] => US [patent_app_date] => 2011-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26917 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0313/20110313154.pdf [firstpage_image] =>[orig_patent_app_number] => 13218946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7657492 [patent_doc_number] => 20110306761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-15 [patent_title] => 'Process For Preparing Prophyrin Derivatives, Such As Protoprophyrin (IX) And Synthesis Intermediates' [patent_app_type] => utility [patent_app_number] => 13/218149 [patent_app_country] => US [patent_app_date] => 2011-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10939 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20110306761.pdf [firstpage_image] =>[orig_patent_app_number] => 13218149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10122498 [patent_doc_number] => 09156849 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-13 [patent_title] => 'Application of β-functionalized dihydroxy-chlorins for PDT' [patent_app_type] => utility [patent_app_number] => 13/208917 [patent_app_country] => US [patent_app_date] => 2011-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 14 [patent_no_of_words] => 12254 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13208917 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056163 [patent_doc_number] => 20120077799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'HETEROCYCLIC COMPOUND AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/206113 [patent_app_country] => US [patent_app_date] => 2011-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 126861 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077799.pdf [firstpage_image] =>[orig_patent_app_number] => 13206113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7768054 [patent_doc_number] => 20120035194 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'SUBSTITUTED 2-AMINO-FUSED HETEROCYCLIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 13/204741 [patent_app_country] => US [patent_app_date] => 2011-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55774 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20120035194.pdf [firstpage_image] =>[orig_patent_app_number] => 13204741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9762354 [patent_doc_number] => 08846678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-09-30 [patent_title] => 'Pyridazine derivatives and use thereof as medicaments for treating microRNA viral infection' [patent_app_type] => utility [patent_app_number] => 13/813806 [patent_app_country] => US [patent_app_date] => 2011-08-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6062 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13813806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8452680 [patent_doc_number] => 20120263625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-18 [patent_title] => 'GLYCO-SUBSTITUTED DIHYDROXY-CHLORINS AND ß-FUNCTIONALIZED CHLORINS FOR ANTI-MICROBIAL PHOTODYNAMIC THERAPY' [patent_app_type] => utility [patent_app_number] => 13/189113 [patent_app_country] => US [patent_app_date] => 2011-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8114 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13189113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8951446 [patent_doc_number] => 20130197226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF LEFT VENTRICULAR DIASTOLIC DYSFUNCTION COMPRISING AN APOLIPOPROTEIN PEPTIDE/PHOSPHOLIPID COMPLEX' [patent_app_type] => utility [patent_app_number] => 13/812376 [patent_app_country] => US [patent_app_date] => 2011-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 29255 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13812376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186735 [patent_doc_number] => 20120115874 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'PYRAZINE DERIVATIVES, PROCESS FOR MANUFACTURE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/254653 [patent_app_country] => US [patent_app_date] => 2011-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6270 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115874.pdf [firstpage_image] =>[orig_patent_app_number] => 13254653 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10110004 [patent_doc_number] => 09145407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-09-29 [patent_title] => 'Sulfonamide compounds' [patent_app_type] => utility [patent_app_number] => 13/808625 [patent_app_country] => US [patent_app_date] => 2011-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24944 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13808625 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7511499 [patent_doc_number] => 20110257209 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => '6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW POTENT ANALGESICS AND ANTI-INFLAMMATORY AGENTS' [patent_app_type] => utility [patent_app_number] => 13/169350 [patent_app_country] => US [patent_app_date] => 2011-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10035 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0257/20110257209.pdf [firstpage_image] =>[orig_patent_app_number] => 13169350 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587542 [patent_doc_number] => 20110282052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'METALLOCENYL PHTHALOCYANINE COMPOUNDS AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/168775 [patent_app_country] => US [patent_app_date] => 2011-06-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7547 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20110282052.pdf [firstpage_image] =>[orig_patent_app_number] => 13168775 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7487717 [patent_doc_number] => 20110251203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-13 [patent_title] => 'USE OF PKC INHIBITORS IN DIABETIC COMPLICATIONS' [patent_app_type] => utility [patent_app_number] => 13/166270 [patent_app_country] => US [patent_app_date] => 2011-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7005 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0251/20110251203.pdf [firstpage_image] =>[orig_patent_app_number] => 13166270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7784744 [patent_doc_number] => 20120046300 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-23 [patent_title] => 'Quinazoline Derivatives as Angiogenesis Inhibitors' [patent_app_type] => utility [patent_app_number] => 13/164310 [patent_app_country] => US [patent_app_date] => 2011-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40646 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20120046300.pdf [firstpage_image] =>[orig_patent_app_number] => 13164310 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7791592 [patent_doc_number] => 20120053148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'INHIBITORS OF HEPATITIS C VIRUS' [patent_app_type] => utility [patent_app_number] => 13/157127 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 89849 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20120053148.pdf [firstpage_image] =>[orig_patent_app_number] => 13157127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8653227 [patent_doc_number] => 08372976 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Methods of treatment comprising the administration of heteroaryl compounds' [patent_app_type] => utility [patent_app_number] => 13/156462 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 118615 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 554 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13156462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199392 [patent_doc_number] => 20120122847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'AURORA KINASE MODULATORS AND METHOD OF USE' [patent_app_type] => utility [patent_app_number] => 13/157195 [patent_app_country] => US [patent_app_date] => 2011-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 67372 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122847.pdf [firstpage_image] =>[orig_patent_app_number] => 13157195 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7651901 [patent_doc_number] => 20110301170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-08 [patent_title] => 'Inhibitors of JNK' [patent_app_type] => utility [patent_app_number] => 13/151323 [patent_app_country] => US [patent_app_date] => 2011-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16728 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0301/20110301170.pdf [firstpage_image] =>[orig_patent_app_number] => 13151323 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10882701 [patent_doc_number] => 08907081 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-09 [patent_title] => 'Long wavelength absorbing porphyrin photosensitizers for dye-sensitized solar cells' [patent_app_type] => utility [patent_app_number] => 13/117529 [patent_app_country] => US [patent_app_date] => 2011-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 16 [patent_no_of_words] => 4793 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13117529 [rel_patent_id] =>[rel_patent_doc_number] =>)